Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-3971

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-3971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure of venlafaxine hydrochloride, illustrating its molecular configuration with labeled functional groups including a methoxy-substituted phenyl ring and an alcohol group connected to a cyclohexane ring, along with the hydrochloride component.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A scatter plot showing fold changes and 90% confidence intervals for pharmacokinetic (PK) parameters Cmax and AUC of venlafaxine and its active metabolite ODV across various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age above 60 years, and gender. The x-axis represents change relative to a reference value, ranging from 0 to about 3.5.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A scatter plot chart depicting fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its ODV analyte when co-administered with various interacting drugs such as ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis shows change relative to the reference value ranging from 0 to 3.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
A forest plot chart showing the fold change and 90% confidence intervals for various pharmacokinetic parameters (Cmax and AUC) of different interacting drugs and analytes relative to a reference value. The drugs analyzed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, toltubamide, and lithium. The x-axis represents fold change values from 0 to 3 on a logarithmic scale, with points and error bars indicating the fold changes and confidence intervals.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Venlafaxine Hydrochloride 37.5 mg extended-release capsules. Package contains 30 capsules. Label indicates prescription use only, includes barcodes, manufacturer Epic Pharma, and repackager RemedyRepack Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.